Human mast cell carboxypeptidase. Selective localization to MCTC cells

A M Irani(Virginia Commonwealth University Medical Center), Sanford Goldstein(Virginia Commonwealth University Medical Center), Bruce U. Wintroub(Virginia Commonwealth University Medical Center), T R Bradford(Virginia Commonwealth University Medical Center), Louis B. Schwartz(Virginia Commonwealth University Medical Center)
The Journal of Immunology
July 1, 1991
Cited by 155

Abstract

Two murine mAb were prepared against human mast cell carboxypeptidase (HMC-CP) purified from human skin, and were termed CP1 and CP2, respectively. Double immunohistochemical labeling of Carnoy's-fixed sections of human skin, lung, and gastrointestinal tissue with CP1 and CP2, respectively, and with a murine monoclonal antitryptase antibody demonstrated that HMC-CP was selectively present in a subset of human mast cells. Double labeling experiments with CP1 and CP2, respectively, and a murine anti-chymase mAb demonstrated the presence of HMC-CP in the tryptase-positive, chymase-positive mast cell type (MCTC) only. Immunohistochemical labeling of peripheral blood leukocytes resulted in staining of monocytes with CP2 but not with CP1. In addition to chymase and a cathepsin-G like proteinase, HMC-CP is another neutral protease that is selectively present in the MCTC tryptase-positive, chymase-positive mast cells type of mast cell, thus extending the biochemical definition of human mast cell heterogeneity.


Related Papers

No related papers found

Powered by citation graph analysis